0001193805-24-000282.txt : 20240228
0001193805-24-000282.hdr.sgml : 20240228
20240228171955
ACCESSION NUMBER: 0001193805-24-000282
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20240226
FILED AS OF DATE: 20240228
DATE AS OF CHANGE: 20240228
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Vitt Daniel
CENTRAL INDEX KEY: 0001773673
ORGANIZATION NAME:
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 001-36201
FILM NUMBER: 24697053
MAIL ADDRESS:
STREET 1: IMMUNIC AG
STREET 2: AM KLOPFERSPITZ 19
CITY: MARTINSRIED
STATE: 2M
ZIP: 82152
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: IMMUNIC, INC.
CENTRAL INDEX KEY: 0001280776
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
ORGANIZATION NAME: 03 Life Sciences
IRS NUMBER: 562358443
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 1200 AVENUE OF THE AMERICAS
STREET 2: SUITE 200
CITY: NEW YORK
STATE: X1
ZIP: 10036
BUSINESS PHONE: (332) 255-9818
MAIL ADDRESS:
STREET 1: 1200 AVENUE OF THE AMERICAS
STREET 2: SUITE 200
CITY: NEW YORK
STATE: X1
ZIP: 10036
FORMER COMPANY:
FORMER CONFORMED NAME: VITAL THERAPIES INC
DATE OF NAME CHANGE: 20040219
4
1
e619306_4-vitt.xml
X0508
4
2024-02-26
0
0001280776
IMMUNIC, INC.
IMUX
0001773673
Vitt Daniel
1200 AVENUE OF THE AMERICAS, SUITE 200
NEW YORK
NY
10036
1
1
0
0
President and CEO
0
Common Stock
2024-02-26
4
P
0
14000
1.3095
A
390877
I
See footnote
14,000 shares of Immunic, Inc. common stock are owned directly by the Reporting Person, and 362,877 shares of Immunic, Inc. common stock are owned by Listrax UG (haftungsbeschrankt). The Reporting Person is Managing Director of Listrax UG and exercises voting and dispositive power over such shares. The spouse of the Reporting Person acquired 14,000 shares of Immunic, Inc. common stock on February 26, 2024.
/s/ Daniel Vitt
2024-02-28